Fig. 3.

Foxp3 vaccine reduces MDSC. The splenocytes and tumor cells from Foxp3-vaccinated or control mice 13 day post-tumor challenge were analyzed for Gr-1 and CD11b using flow cytometry (n = 6 mice per group). a Representative dot plots indicating Gr1⁺CD11b⁺ cells in Foxp3 vaccinated versus control mice. b Percentages of Gr1⁺CD11b⁺ cells in splenocytes versus tumor cells. Data represent mean ± one standard error of two independent experiments